Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type
Conditions
Interventions
None listed
Sponsors
Shiva Trust Yashwantrao Chavan Ayurvedic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: Children fulfilling DSM- V criteria for ADHD. And Already diagnosed patients of ADHD
Exclusion criteria
Exclusion criteria: 1) Known cases of any acute or chronic illnesses e.g TB, malignancy and on chronic medication etc. 2) Known cases of seizures, Epilepsy, Bipolar Disorder etc. 3)Children below 4 years and above 16 years will be excluded from study. 4) Children with seizures and recurrent upper respiratory infections will be excluded from the trial due to potential drug interactions & possibility of infections. 5) Children with medical illness like hearing loss,hypothyroidism,vision loss, genetic disorder, co-morbid conditions such as cerebral palsy, mental retardation. 6) Children having congenital deformity or Muscular dystrophy and other chronic neurological & metabolic disorders will be excluded from the study. 7) Children who are taking any type ayurvedic medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Jatamansi taila and Jatamansoi taila shiroabhyanga in the management of ADHD.Timepoint: 90 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1) To explore about the Attention- Deficit Hyperactivity Disorder from Modern point of view. 2) To explore about the Attention- Deficit Hyperactivity Disorder from Ayurvedic point of view. 3) To study the properties of drugs used in the study. 4) To evaluate the effect of Phanta and Shiroabhyanga in ADHD children aged 4 16 years.Timepoint: 18 months | — |
Countries
India
Contacts
Public ContactDr Snehal Kale
Shiva Trusts Yashwantrao Chavan Ayurvedic Medical College and Hospital Aurangabad
Outcome results
None listed